Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Ulrike Flierl, Tracy L Nero, Bock Lim, Jane F Arthur, Yu Yao, Stephanie M Jung, Eelo Gitz, Alice Y Pollitt, Maria TK Zaldivia, Martine Jandrot-Perrus, Andreas Schaefer, Bernhard Nieswandt, Robert K Andrews, Michael W Parker, Elizabeth E Gardiner, Karlheinz Peter
JOURNAL OF EXPERIMENTAL MEDICINE | ROCKEFELLER UNIV PRESS | Published : 2015
Awarded by British Heart Foundation
This work was supported by the German Research Foundation, a British Heart Foundation Chair account (Prof. Steve Watson), and the National Health and Medical Research Council of Australia.